168 related articles for article (PubMed ID: 37031328)
1. Immunological and prognostic significance of tumour necrosis in colorectal cancer.
Kastinen M; Sirniö P; Elomaa H; Ahtiainen M; Väyrynen SA; Herzig KH; Meriläinen S; Aro R; Häivälä R; Rautio T; Saarnio J; Wirta EV; Helminen O; Seppälä TT; Kuopio T; Böhm J; Tuomisto A; Mecklin JP; Mäkinen MJ; Väyrynen JP
Br J Cancer; 2023 Jun; 128(12):2218-2226. PubMed ID: 37031328
[TBL] [Abstract][Full Text] [Related]
2. Clinical impact and network of determinants of tumour necrosis in colorectal cancer.
Väyrynen SA; Väyrynen JP; Klintrup K; Mäkelä J; Karttunen TJ; Tuomisto A; Mäkinen MJ
Br J Cancer; 2016 Jun; 114(12):1334-42. PubMed ID: 27195424
[TBL] [Abstract][Full Text] [Related]
3. High-serum MMP-8 levels are associated with decreased survival and systemic inflammation in colorectal cancer.
Sirniö P; Tuomisto A; Tervahartiala T; Sorsa T; Klintrup K; Karhu T; Herzig KH; Mäkelä J; Karttunen TJ; Salo T; Mäkinen MJ; Väyrynen JP
Br J Cancer; 2018 Jul; 119(2):213-219. PubMed ID: 29808017
[TBL] [Abstract][Full Text] [Related]
4. Immune response gene expression in colorectal cancer carries distinct prognostic implications according to tissue, stage and site: a prospective retrospective translational study in the context of a hellenic cooperative oncology group randomised trial.
Pentheroudakis G; Raptou G; Kotoula V; Wirtz RM; Vrettou E; Karavasilis V; Gourgioti G; Gakou C; Syrigos KN; Bournakis E; Rallis G; Varthalitis I; Galani E; Lazaridis G; Papaxoinis G; Pectasides D; Aravantinos G; Makatsoris T; Kalogeras KT; Fountzilas G
PLoS One; 2015; 10(5):e0124612. PubMed ID: 25970543
[TBL] [Abstract][Full Text] [Related]
5. Tumour-infiltrating inflammation and prognosis in colorectal cancer: systematic review and meta-analysis.
Mei Z; Liu Y; Liu C; Cui A; Liang Z; Wang G; Peng H; Cui L; Li C
Br J Cancer; 2014 Mar; 110(6):1595-605. PubMed ID: 24504370
[TBL] [Abstract][Full Text] [Related]
6. Prognostic significance of spatial and density analysis of T lymphocytes in colorectal cancer.
Elomaa H; Ahtiainen M; Väyrynen SA; Ogino S; Nowak JA; Friman M; Helminen O; Wirta EV; Seppälä TT; Böhm J; Mäkinen MJ; Mecklin JP; Kuopio T; Väyrynen JP
Br J Cancer; 2022 Aug; 127(3):514-523. PubMed ID: 35449453
[TBL] [Abstract][Full Text] [Related]
7. Tumour infiltrating lymphocyte status is superior to histological grade, DNA mismatch repair and BRAF mutation for prognosis of colorectal adenocarcinomas with mucinous differentiation.
Williams DS; Mouradov D; Newman MR; Amini E; Nickless DK; Fang CG; Palmieri M; Sakthianandeswaren A; Li S; Ward RL; Hawkins NJ; Skinner I; Jones I; Gibbs P; Sieber OM
Mod Pathol; 2020 Jul; 33(7):1420-1432. PubMed ID: 32047231
[TBL] [Abstract][Full Text] [Related]
8. Dual role of tumour-infiltrating T helper 17 cells in human colorectal cancer.
Amicarella F; Muraro MG; Hirt C; Cremonesi E; Padovan E; Mele V; Governa V; Han J; Huber X; Droeser RA; Zuber M; Adamina M; Bolli M; Rosso R; Lugli A; Zlobec I; Terracciano L; Tornillo L; Zajac P; Eppenberger-Castori S; Trapani F; Oertli D; Iezzi G
Gut; 2017 Apr; 66(4):692-704. PubMed ID: 26719303
[TBL] [Abstract][Full Text] [Related]
9. CXCL8 expression is associated with advanced stage, right sidedness, and distinct histological features of colorectal cancer.
Pennel KA; Quinn JA; Nixon C; Inthagard J; van Wyk HC; Chang D; Rebus S; ; Hay J; Maka NN; Roxburgh CS; Horgan PG; McMillan DC; Park JH; Roseweir AK; Steele CW; Edwards J
J Pathol Clin Res; 2022 Nov; 8(6):509-520. PubMed ID: 35879507
[TBL] [Abstract][Full Text] [Related]
10. Systemic inflammation is associated with circulating cell death released keratin 18 fragments in colorectal cancer.
Sirniö P; Väyrynen JP; Mutt SJ; Herzig KH; Walkowiak J; Klintrup K; Mäkelä J; Karttunen TJ; Mäkinen MJ; Tuomisto A
Oncoimmunology; 2020 Jun; 9(1):1783046. PubMed ID: 32923147
[TBL] [Abstract][Full Text] [Related]
11. Lymphocytic response to tumour and deficient DNA mismatch repair identify subtypes of stage II/III colorectal cancer associated with patient outcomes.
Williams DS; Mouradov D; Jorissen RN; Newman MR; Amini E; Nickless DK; Teague JA; Fang CG; Palmieri M; Parsons MJ; Sakthianandeswaren A; Li S; Ward RL; Hawkins NJ; Faragher I; Jones IT; Gibbs P; Sieber OM
Gut; 2019 Mar; 68(3):465-474. PubMed ID: 29382774
[TBL] [Abstract][Full Text] [Related]
12. Prognostic impact of immune response in resectable colorectal liver metastases treated by surgery alone or surgery with perioperative FOLFOX in the randomised EORTC study 40983.
Tanis E; Julié C; Emile JF; Mauer M; Nordlinger B; Aust D; Roth A; Lutz MP; Gruenberger T; Wrba F; Sorbye H; Bechstein W; Schlag P; Fisseler A; Ruers T
Eur J Cancer; 2015 Nov; 51(17):2708-17. PubMed ID: 26342674
[TBL] [Abstract][Full Text] [Related]
13. Mismatch repair status in patients with primary operable colorectal cancer: associations with the local and systemic tumour environment.
Park JH; Powell AG; Roxburgh CS; Horgan PG; McMillan DC; Edwards J
Br J Cancer; 2016 Mar; 114(5):562-70. PubMed ID: 26859693
[TBL] [Abstract][Full Text] [Related]
14. Intraepithelial tumour infiltrating lymphocytes are associated with absence of tumour budding and immature/myxoid desmoplastic reaction, and with better recurrence-free survival in stages I-III colorectal cancer.
González IA; Bauer PS; Liu J; Chatterjee D
Histopathology; 2021 Jan; 78(2):252-264. PubMed ID: 32654226
[TBL] [Abstract][Full Text] [Related]
15. The in situ local immune response, tumour senescence and proliferation in colorectal cancer.
Roxburgh CS; Richards CH; Macdonald AI; Powell AG; McGlynn LM; McMillan DC; Horgan PG; Edwards J; Shiels PG
Br J Cancer; 2013 Oct; 109(8):2207-16. PubMed ID: 24022192
[TBL] [Abstract][Full Text] [Related]
16. CD3+ cells at the invasive margin of deeply invading (pT3-T4) colorectal cancer and risk of post-surgical metastasis: a longitudinal study.
Laghi L; Bianchi P; Miranda E; Balladore E; Pacetti V; Grizzi F; Allavena P; Torri V; Repici A; Santoro A; Mantovani A; Roncalli M; Malesci A
Lancet Oncol; 2009 Sep; 10(9):877-84. PubMed ID: 19656725
[TBL] [Abstract][Full Text] [Related]
17. The clinical impact of tumour-infiltrating lymphocytes in colorectal cancer differs by anatomical subsite: A cohort study.
Berntsson J; Svensson MC; Leandersson K; Nodin B; Micke P; Larsson AH; Eberhard J; Jirström K
Int J Cancer; 2017 Oct; 141(8):1654-1666. PubMed ID: 28677162
[TBL] [Abstract][Full Text] [Related]
18. Comparison of visual and automated assessment of tumour inflammatory infiltrates in patients with colorectal cancer.
Forrest R; Guthrie GJ; Orange C; Horgan PG; McMillan DC; Roxburgh CS
Eur J Cancer; 2014 Feb; 50(3):544-52. PubMed ID: 24332571
[TBL] [Abstract][Full Text] [Related]
19. Increased serum levels of tumour-associated trypsin inhibitor independently predict a poor prognosis in colorectal cancer patients.
Gaber A; Nodin B; Hotakainen K; Nilsson E; Stenman UH; Bjartell A; Birgisson H; Jirström K
BMC Cancer; 2010 Sep; 10():498. PubMed ID: 20849596
[TBL] [Abstract][Full Text] [Related]
20. Cancer-associated fibroblasts impact the clinical outcome and treatment response in colorectal cancer via immune system modulation: a comprehensive genome-wide analysis.
Chen YF; Yu ZL; Lv MY; Cai ZR; Zou YF; Lan P; Wu XJ; Gao F
Mol Med; 2021 Oct; 27(1):139. PubMed ID: 34717544
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
